Taken together, our data suggest that inhibition of VEGF/VEGFR2 signaling stimulates the activation of tumor-infiltrating T cells and facilitates the functional activity of CTLs in TB animals, which might be attributed to the inhibition of VEGFR2+ immunosuppressive myeloid cells. Here, KDR is linked to neoplasm.